---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-21-000061"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2021-08-02T23:59:59+00:00"
generated_at: "2026-06-30T00:02:32.145060+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Immunovant receives $200M investment from Roivant at 15% premium to VWAP

## Summary
- Roivant purchases 17,021,276 shares at $11.75/share ($200M gross proceeds), a 15% premium to 20-day VWAP.
- Roivant's ownership increases from 57.5% to 63.8%; Immunovant pro forma cash ~$600M.
- Proceeds to fund development of IMVT-1401; pivotal trial for myasthenia gravis planned within 12 months.
- Dr. Frank Torti appointed Executive Chairperson, effective immediately, no additional compensation.
- Investment approved by special committee of independent directors.

## SEC filing metadata
- accession: 0001764013-21-000061
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2021-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000061/0001764013-21-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000061/imvt-20210802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-21-000061
- JSON: https://secwatch.observer/filing/0001764013-21-000061.json
- Plain text: https://secwatch.observer/filing/0001764013-21-000061.txt

## Key facts
- Executive change
  Dr. Frank M. Torti was appointed as Executive Chairperson at Immunovant, Inc..
  - Action: appointed
  - Role: Executive Chairperson
  source text: Effective August 2, 2021, Dr. Frank M. Torti, age 42, Immunovant’s current Chairperson, was appointed Executive Chairperson.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000061/0001764013-21-000061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.